Are high coronary risk patients missing out on lipid-lowering drugs in Australia?
Med J Aust
; 201(4): 213-6, 2014 Aug 18.
Article
en En
| MEDLINE
| ID: mdl-25164848
ABSTRACT
OBJECTIVE:
To examine whether high coronary risk patients in Australia, where use of lipid-lowering drugs (LLD) is very high by international standards, are receiving LLD. DESIGN, SETTING AND PATIENTS Assessment of Pharmaceutical Benefits Scheme pharmacy payment claim records between January 2006 and May 2013 for a 10% random sample of Australian concession card holders. Co-prescriptions were used as a surrogate for high coronary risk groups - coronary heart disease (CHD) antiplatelet drugs (not including solo aspirin) and anti-anginal drugs; diabetes all standard drugs; hypertension all standard drugs (not including solo diuretics). MAIN OUTCOMEMEASURE:
Proportions of patients in high-risk groups not receiving LLD (statins, fibrates or ezetimibe).RESULTS:
The database yielded information on 276,212 patients defined as being at high coronary risk (mean age, 66.1 [SD, 14.8] years; 44% male). Of this group, 115,477 patients (42%) had not received any LLD during the study period. For patients in the risk group for CHD in combination with diabetes and hypertension, only 8% (1111/14,257) were not receiving LLD. Across all risk groups, the proportions not receiving LLD were generally highest in those aged ≥ 81 years and, to a lesser extent, < 41 years, and were lowest in those aged 51-70 years.CONCLUSION:
A large proportion of concession card holders at high coronary risk, especially those in middle age with CHD and multiple risk factors, are being appropriately prescribed LLD in Australia.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Enfermedad Coronaria
/
Hipolipemiantes
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
País/Región como asunto:
Oceania
Idioma:
En
Revista:
Med J Aust
Año:
2014
Tipo del documento:
Article
País de afiliación:
Australia